These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Slama G; Hautecouverture M; Assan R; Tchobroutsky G Diabetes; 1974 Sep; 23(9):732-8. PubMed ID: 4414927 [No Abstract] [Full Text] [Related]
23. Low-dose insulin infusions in diabetic patients with high insulin requirements. Dandona P; Foster M; Healey F; Greenbury E; Beckett AG Lancet; 1978 Aug; 2(8084):283-5. PubMed ID: 79081 [TBL] [Abstract][Full Text] [Related]
24. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs. Braithwaite SS Semin Thorac Cardiovasc Surg; 2006; 18(4):366-78. PubMed ID: 17395034 [TBL] [Abstract][Full Text] [Related]
25. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019 [TBL] [Abstract][Full Text] [Related]
26. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. White NH; Skor DA; Cryer PE; Levandoski LA; Bier DM; Santiago JV N Engl J Med; 1983 Mar; 308(9):485-91. PubMed ID: 6337335 [TBL] [Abstract][Full Text] [Related]
28. Medical Grand Rounds. Open and closed loop insulin delivery systems in diabetes: current status. Service FJ Henry Ford Hosp Med J; 1982; 30(3):163-7. PubMed ID: 6761321 [No Abstract] [Full Text] [Related]
29. What are the disadvantages of sliding-scale insulin? Michota F J Hosp Med; 2007; 2 Suppl 1():20-2. PubMed ID: 17311240 [No Abstract] [Full Text] [Related]
30. Diets for insulin pump and multiple daily injection therapy. Grinvalsky M; Nathan DM Diabetes Care; 1983; 6(3):241-4. PubMed ID: 6347575 [TBL] [Abstract][Full Text] [Related]
31. Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system. Bayliss J Br Med J (Clin Res Ed); 1981 Nov; 283(6301):1207-9. PubMed ID: 6797511 [TBL] [Abstract][Full Text] [Related]
32. [Continuous subcutaneous and intravenous infusions of insulin with predetermined or auto-adjusted flow]. Hepp KD; Renner R; Mehnert H; Franetzki M Journ Annu Diabetol Hotel Dieu; 1980 May; ():23-33. PubMed ID: 6995670 [No Abstract] [Full Text] [Related]
33. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
34. Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus. Irsigler K; Kritz H Diabetes; 1979 Mar; 28(3):196-203. PubMed ID: 446904 [TBL] [Abstract][Full Text] [Related]